Date Filed | Type | Description |
05/31/2023 |
4
| MacLeod Roderick H. (CFO) has filed a Form 4 on NEVRO CORP
Txns:
| Paid exercise price by delivering 800 shares
@ $26.45, valued at
$21.2k
|
|
03/09/2023 |
4
| MacLeod Roderick H. (CFO) has filed a Form 4 on NEVRO CORP
Txns:
| Granted 39,282 shares
@ $0 |
|
03/06/2023 |
4
| MacLeod Roderick H. (CFO) has filed a Form 4 on NEVRO CORP
Txns:
| Paid exercise price by delivering 1,133 shares
@ $33.99, valued at
$38.5k
|
|
03/02/2023 |
4
| MacLeod Roderick H. (CFO) has filed a Form 4 on NEVRO CORP
Txns:
| Paid exercise price by delivering 3,352 shares
@ $31.44, valued at
$105.4k
|
|
06/17/2022 |
4
| MacLeod Roderick H. (CFO) has filed a Form 4 on NEVRO CORP
Txns:
| Paid exercise price by delivering 1,579 shares
@ $42.25, valued at
$66.7k
|
|
03/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/16/2021 |
4
| MacLeod Roderick H. (CFO) has filed a Form 4 on NEVRO CORP
Txns:
| Paid exercise price by delivering 1,583 shares
@ $158.49, valued at
$250.9k
|
|
03/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/17/2020 |
4
| MacLeod Roderick H. (CFO) has filed a Form 4 on NEVRO CORP
Txns:
| Granted 12,052 shares
@ $0 |
|
06/17/2020 |
3
| MacLeod Roderick H. (CFO) has filed a Form 3 on NEVRO CORP |